diazooxonorleucine has been researched along with Carcinoma, Ehrlich Tumor in 6 studies
*Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, SM; Jha, T; Panda, P; Samanta, S | 1 |
| Adhikary, N; Halder, AK; Jha, T; Maity, MK | 1 |
| Banerjee, M; Ghosh, S; Maity, P; Roy, S | 1 |
| Johnstone, RM; Trachewsky, D | 1 |
| Chu, SY; Henderson, JF | 1 |
| Neal, AL; Smulson, ME | 1 |
6 other study(ies) available for diazooxonorleucine and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Possible anticancer agents: QSAR analogs of glutamamide: synthesis and pharmacological activity of 1,5-N,N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides.
Topics: Amides; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Glutamates; Humans; Mice; Quantitative Structure-Activity Relationship; Tumor Burden | 2009 |
Synthesis, pharmacological activity and comparative QSAR modeling of 1,5-N,N'-substituted-2-(substituted naphthalenesulphonyl) glutamamides as possible anticancer agents.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Glutamine; Male; Mice; Models, Molecular; Molecular Structure; Neoplasm Transplantation; Neoplasms, Experimental; Quantitative Structure-Activity Relationship; Stereoisomerism; Structure-Activity Relationship | 2010 |
Modulation of tumor induced angiogenesis in Ehrlich ascites tumor.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Proliferation; Diazooxonorleucine; Dose-Response Relationship, Drug; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Mice; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Ovarian Neoplasms; Time Factors; Vascular Endothelial Growth Factor A | 2004 |
Utilization of ammonium ions for purine precursor synthesis in soluble extracts of Ehrlich ascites cells.
Topics: Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Cell Line; Cell-Free System; Deoxyribonucleotides; Diazooxonorleucine; Formates; Glucose; Glutamine; Glycine; Hydrogen-Ion Concentration; Mice; NADP; Neoplasms, Experimental; Nucleic Acids; Nucleotides; Protein Biosynthesis; Purines; Pyrimidines; Quaternary Ammonium Compounds; Ribonucleotides; Serine; Sodium | 1969 |
Inhibition of the phosphoribosyl-formylglycineamidine synthetase of Ehrlich ascites tumor cells by glutamine analogues.
Topics: Animals; Azaserine; Carcinoma, Ehrlich Tumor; Diazooxonorleucine; Glutamine; Glycine; Kinetics; Ligases; Osmolar Concentration; Parabens; Pentosephosphates; Protein Binding | 1972 |
Comparative effects of glutamine analogues on protein metabolism of 6C3H-ED and Ehrlich ascites carcinoma.
Topics: Amides; Animals; Azaserine; Azides; Carcinoma, Ehrlich Tumor; Diazooxonorleucine; Glutamine; Hydroxamic Acids; In Vitro Techniques; Isoleucine; Lymphoma, Non-Hodgkin; Methionine; Methionine Sulfoximine; Neoplasm Proteins; Sarcoma, Experimental; Valine | 1965 |